Circulating microRNAs can predict chemotherapy-induced toxicities in patients being treated for primary breast cancer
ConclusionThis is the first study which illustrates the value of measuring circulatory miRNA to predict patient-specific toxicities to NAC. These results support the ideology that circulatory miRNAs are biomarkers with utility in predicting chemotherapy toxicity as well as treatment response.
Source: Breast Cancer Research and Treatment - Category: Cancer & Oncology Source Type: research
More News: Anemia | Brain | Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | Genetics | Ireland Health | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Neurology | Peripheral Neuropathy | Study | Toxicology